1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: North America Marine Biotechnology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. North America Marine Biotechnology Market Revenue and Volume, by Source
8.1.1 Corals and sponges
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Algae
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Marine Viruses
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Marine Fungi
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast
9.1. North America Marine Biotechnology Market Revenue and Volume, by Application
9.1.1. Aquaculture & Fishery
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Medicine
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Environment
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Biofuels
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. North America Marine Biotechnology Market Revenue and Volume, by End User
10.1.1. Medical & Pharmaceutical
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Food Industry
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Cosmetics Industry
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Chemical Industry
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. U.S.
11.1.1. Market Revenue and Volume Forecast, by Device Type
11.1.2. Market Revenue and Volume Forecast, by Display Type
11.1.3. Market Revenue and Volume Forecast, by Size
11.1.4. Market Revenue and Volume Forecast, by Display Technology
11.1.5. Market Revenue and Volume Forecast, by End-user
11.1.6.1. Rest of North America
11.1.6.2. Market Revenue and Volume Forecast, by Device Type
11.1.6.3. Market Revenue and Volume Forecast, by Display Type
11.1.6.4. Market Revenue and Volume Forecast, by Size
11.1.6.5. Market Revenue and Volume Forecast, by Display Technology
11.1.6.6. Market Revenue and Volume Forecast, by End-user
12.1. Abbott
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Aker Biomarine
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Biolume Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cp Kelco
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cyanotech Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. FMC Geomarine Biotech
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Lonza Group Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. FMC Health And Nutrition
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Nutrex Hawaii Incorporated
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Phyco Biotech Sas
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client